文献速递中医内科中药与中成药合理使用

中药注射剂治疗心脑血管疾病:概述与挑战

Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges.
PubMed 文献 · Front Pharmacol · 2023-02-24

心脑血管疾病是全球主要死因且缺乏最优治疗方案,中药注射剂(CHI)结合中医理论与现代生产技术,在急危重症尤其心脑血管疾病中显示独特治疗优势。本文综述常用CHI的临床应用、药理作用及机制,分析不良反应原因,并提出合理用药与药学监护建议。

要点

  • 活血化瘀类中药(丹参、红花、三七、川芎)占心脑血管CHI较大比例。
  • CHI具抗血小板聚集、抗炎、抗纤维化、抗凋亡等潜在药理活性。
  • 直接入血可能产生新药理效应或不良反应,需关注合理用药与监护。

核心结论

  • 中药注射剂在急危重症尤其心脑血管疾病治疗中起重要作用并具独特治疗优势。
  • 需针对不同品种CHI分析不良反应原因并提出合理用药与药学监护建议。

研究设计与样本

  • 综述类文章,总结不同品种CHI治疗心脑血管疾病的临床应用、药理作用及作用机制。

主要发现

  • 活血化瘀类中药如丹参、红花、三七、川芎占心脑血管CHI较大比例。
  • CHI具有抗血小板聚集、抗炎、抗纤维化、抗凋亡等潜在药理活性。
  • CHI改变传统给药方式,药物直接入血可能产生新药理效应或不良反应。

临床怎么用

  • 临床可参考本文总结的CHI品种临床应用与药理机制进行合理选用。
  • 使用CHI时应关注其直接入血可能带来的不良反应并加强药学监护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardio-cerebrovascular diseases are the leading cause of death worldwide and there is currently no optimal treatment plan. Chinese herbal medicine injection (CHI) is obtained by combining traditional Chinese medicine (TCM) theory and modern production technology. It retains some characteristics of TCM while adding injection characteristics. CHI has played an important role in the treatment of critical diseases, especially cardio-cerebrovascular diseases, and has shown unique therapeutic advantages. TCMs that promote blood circulation and remove blood stasis, such as Salvia miltiorrhiza, Carthami flos, Panax notoginseng, and Chuanxiong rhizoma, account for a large proportion of CHIs of cardio-cerebrovascular disease. CHI is used to treat cardio-cerebrovascular diseases and has potential pharmacological activities such as anti-platelet aggregation, anti-inflammatory, anti-fibrosis, and anti-apoptosis. However, CHIs have changed the traditional method of administering TCMs, and the drugs directly enter the bloodstream, which may produce new pharmacological effects or adverse reactions. This article summarizes the clinical application, pharmacological effects, and mechanism of action of different varieties of CHIs commonly used in the treatment of cardio-cerebrovascular diseases, analyzes the causes of adverse reactions, and proposes suggestions for rational drug use and pharmaceutical care methods to provide a reference for the rational application of CHIs for cardio-cerebrovascular diseases.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Huajuan J, Xulong H, Bin X, et al. Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges. Front Pharmacol. 2023. PMID: 36909150. doi:10.3389/fphar.2023.1038906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。